These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1077 related items for PubMed ID: 18469305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Different effect of cyclosporine and tacrolimus on renal expression of P-glycoprotein in human kidney transplantation.
    Yu X, Zhang B, Xing C, Sun B, Liu M, Zhang W, Gu M.
    Transplant Proc; 2008 Dec; 40(10):3455-9. PubMed ID: 19100412
    [Abstract] [Full Text] [Related]

  • 7. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF, Sirolimus CONVERT Trial Study Group.
    Transplantation; 2009 Jan 27; 87(2):233-42. PubMed ID: 19155978
    [Abstract] [Full Text] [Related]

  • 8. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT, Ottosen P, Starklint H, Dieperink H.
    Nephrol Dial Transplant; 2003 Mar 27; 18(3):491-6. PubMed ID: 12584269
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine and rapamycin act in a synergistic and dose-dependent manner in a model of immunosuppressant-induced kidney damage.
    Brook NR, Waller JR, Bicknell GR, Nicholson ML.
    Transplant Proc; 2005 Mar 27; 37(2):837-8. PubMed ID: 15848549
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.
    Pankewycz O, Leca N, Kohli R, Weber-Shrikant E, Said M, Alnimri M, Feng L, Patel S, Laftavi MR.
    Transplant Proc; 2011 Mar 27; 43(2):519-23. PubMed ID: 21440749
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of transforming growth factor-beta-inducible gene-h3 in normal and cyclosporine-treated rat kidney.
    Sun BK, Li C, Lim SW, Jung JY, Lee SH, Kim IS, Kim YS, Kim J, Bang BK, Yang CW.
    J Lab Clin Med; 2004 Mar 27; 143(3):175-83. PubMed ID: 15007308
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF.
    Kidney Int; 2004 Apr 27; 65(4):1262-71. PubMed ID: 15086465
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.